These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32842448)

  • 21. Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists.
    Jiang J; Xu J; Cai L; Man L; Niu L; Hu J; Sun T; Zheng X
    BMC Psychiatry; 2021 Dec; 21(1):624. PubMed ID: 34895183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and related factors of somatization symptoms in outpatients with psychiatric disorders of the department of cardiology in general hospitals].
    Zhang YN; Jin C; Ning L; Gong S; Xiao Y; Yu GL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):907-912. PubMed ID: 31744281
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer.
    Qiu L; Fu F; Huang M; Lin Y; Chen Y; Chen M; Wang C
    Sci Rep; 2016 May; 6():26627. PubMed ID: 27230285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
    Ribi K; Luo W; Bernhard J; Francis PA; Burstein HJ; Ciruelos E; Bellet M; Pavesi L; Lluch A; Visini M; Parmar V; Tondini C; Kerbrat P; Perelló A; Neven P; Torres R; Lombardi D; Puglisi F; Karlsson P; Ruhstaller T; Colleoni M; Coates AS; Goldhirsch A; Price KN; Gelber RD; Regan MM; Fleming GF
    J Clin Oncol; 2016 May; 34(14):1601-10. PubMed ID: 27022111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).
    Gori S; Puglisi F; Cinquini M; Pappagallo G; Frassoldati A; Biganzoli L; Cortesi L; Fiorentino A; Angiolini C; Tinterri C; De Censi A; Levaggi A; Del Mastro L
    Eur J Cancer; 2018 Aug; 99():9-19. PubMed ID: 29886394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
    Lambertini M; Boni L; Michelotti A; Gamucci T; Scotto T; Gori S; Giordano M; Garrone O; Levaggi A; Poggio F; Giraudi S; Bighin C; Vecchio C; Sertoli MR; Pronzato P; Del Mastro L;
    JAMA; 2015 Dec 22-29; 314(24):2632-40. PubMed ID: 26720025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer.
    Park WC
    J Breast Cancer; 2016 Dec; 19(4):341-348. PubMed ID: 28053622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical and psychological correlates of high somatic symptom severity in Chinese breast cancer patients.
    Leonhart R; Tang L; Pang Y; Li J; Song L; Fischer I; Koch M; Wuensch A; Fritzsche K; Schaefert R
    Psychooncology; 2017 May; 26(5):656-663. PubMed ID: 27350559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence.
    Montemurro F; Del Mastro L; De Laurentiis M; Puglisi F
    Expert Rev Anticancer Ther; 2016; 16(2):211-8. PubMed ID: 26634955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Depression and Anxiety in Breast Cancer Patients: Prevalence and Associated Factors.
    Tsaras K; Papathanasiou IV; Mitsi D; Veneti A; Kelesi M; Zyga S; Fradelos EC
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1661-1669. PubMed ID: 29938451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Picking the optimal endocrine adjuvant treatment for pre-menopausal women.
    Colleoni M; Munzone E
    Breast; 2015 Nov; 24 Suppl 2():S11-4. PubMed ID: 26249119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.
    Regan MM; Francis PA; Pagani O; Fleming GF; Walley BA; Viale G; Colleoni M; Láng I; Gómez HL; Tondini C; Pinotti G; Price KN; Coates AS; Goldhirsch A; Gelber RD
    J Clin Oncol; 2016 Jul; 34(19):2221-31. PubMed ID: 27044936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.
    Frampton JE
    Drugs; 2017 Dec; 77(18):2037-2048. PubMed ID: 29177573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rates of depression anxiety and suicidal ideation among inpatients in general hospital in China.
    Huang M; Liu Y; Wang J; Mo L; Wang Y; Chen L; Dong Z; Guo W; He N; Chen R; Luo S; Yu J; Zhang L
    Int J Psychiatry Clin Pract; 2019 Jun; 23(2):99-105. PubMed ID: 30762438
    [No Abstract]   [Full Text] [Related]  

  • 36. The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer.
    Kang YK; Wang X; Hu NL; Yue J; Si YR; Ju J; Gao SL; Yuan P
    Front Oncol; 2021; 11():759595. PubMed ID: 34926260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.
    Chlebowski RT; Pan K; Col NF
    Breast Cancer Res Treat; 2017 Jan; 161(2):185-190. PubMed ID: 27785653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer.
    Conte B; Poggio F; Del Mastro L
    Expert Opin Pharmacother; 2017 Sep; 18(13):1357-1362. PubMed ID: 28764603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
    ; Castiglione-Gertsch M; O'Neill A; Price KN; Goldhirsch A; Coates AS; Colleoni M; Nasi ML; Bonetti M; Gelber RD
    J Natl Cancer Inst; 2003 Dec; 95(24):1833-46. PubMed ID: 14679153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emotional distress and dysfunctional illness perception are associated with low mental and physical quality of life in Chinese breast cancer patients.
    Tang L; Fritzsche K; Leonhart R; Pang Y; Li J; Song L; Fischer I; Koch M; Wuensch A; Mewes R; Schaefert R
    Health Qual Life Outcomes; 2017 Dec; 15(1):231. PubMed ID: 29191208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.